Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

 

Every year, the Clinical Trials on Alzheimer’s Disease conference (CTAD) brings together leaders in academia and industry to share and debate the latest in Alzheimer’s disease therapeutic trials. CTAD 2022 featured highly anticipated late-phase research news, as well as introductions to novel agents, ongoing studies, and cutting-edge clinical trial strategies.

Explore our coverage below!

CTAD 2022

CTAD 2022

 

Every year, the Clinical Trials on Alzheimer’s Disease conference (CTAD) brings together leaders in academia and industry to share and debate the latest in Alzheimer’s disease therapeutic trials. CTAD 2022 featured highly anticipated late-phase research news, as well as introductions to novel agents, ongoing studies, and cutting-edge clinical trial strategies.

Explore our coverage below!